Figure 2From: Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)Admission INRs in the whole cohort (A) and in the ICH subgroup (B). Most patients were in the therapeutic range (INR between 1.5 and 4). ICH, intracranial hemorrhage; INR, international normalized ratio.Back to article page